🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

21+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 21 recruiting trials for “rhabdoid-tumor

Phase 1, PHASE2RecruitingNCT06465199

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

👨‍⚕️ Giselle Saulnier Sholler, MD, Penn State Health Children's Hospital📍 6 sites📅 Started Mar 2026View details ↗
Phase 4RecruitingNCT07176689

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

👨‍⚕️ Winette van der Graff, MD, The Netherlands Cancer Institute📍 20 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07170644

A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

🏥 SpringWorks Therapeutics, Inc.📍 3 sites📅 Started Aug 2025View details ↗
RecruitingNCT06945887

Treatment of Desmoid Fibromatosis With Arterial Embolization

🏥 Istituto Ortopedico Rizzoli📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT07496242

Immunological Phenotype of Desmoid-fibromatosis-affected Patients.

👨‍⚕️ Chiara Colombo, MD, Surgical Oncologist, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano📍 8 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT05879146

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

👨‍⚕️ Keila Torres, MD,PHD, M.D. Anderson Cancer Center📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06622941

Study to ONO-4538 in Patients With Rhabdoid Tumor

👨‍⚕️ Project Leader, Ono Pharmaceutical Co. Ltd📍 5 sites📅 Started Nov 2024View details ↗
RecruitingNCT06660121

Electrochemotherapy for Desmoid Tumors

👨‍⚕️ Giancarlo Facchini, Medicine and Surgery, IRCCS Istituto Ortopedico Rizzoli📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06193759

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

👨‍⚕️ Brian Rood, MD, Children's National Research Institute📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06081400

Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting

👨‍⚕️ Afshin GANGI, MD, PhD, Hôpitaux Universitaires de Strasbourg📍 13 sites📅 Started Mar 2024View details ↗
RecruitingNCT06224283

Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation

🏥 Istituto Ortopedico Rizzoli📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06268457

Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis

🏥 Istituto Ortopedico Rizzoli📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05949099

Study of Cryoablation and Nirogacestat for Desmoid Tumor

👨‍⚕️ Nam Bui, M.D., Stanford University📍 1 site📅 Started Aug 2023View details ↗
Phase 1, PHASE2RecruitingNCT05407441

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

👨‍⚕️ Susan Chi, MD, Dana-Farber Cancer Institute📍 3 sites📅 Started Aug 2023View details ↗
Phase 1RecruitingNCT05835687

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

👨‍⚕️ Christopher DeRenzo, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT05111964

HIFU Ablation of Soft Tissue Sarcoma

👨‍⚕️ Paul C Lyon, FRCR, DPhil, Oxford University Hospitals NHS Trust📍 1 site📅 Started Dec 2021View details ↗
NARecruitingNCT05091255

Cryotherapy in the Treatment of Desmoid Tumors

🏥 Istituto Ortopedico Rizzoli📍 1 site📅 Started May 2021View details ↗
RecruitingNCT04281381

Observing People With Desmoid-Type Fibromatosis

👨‍⚕️ Aimee M Crago, MD, PhD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Feb 2020View details ↗
Phase 1RecruitingNCT04185038

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

👨‍⚕️ Rebecca Ronsley, MD, Seattle Children's Hospital📍 1 site📅 Started Dec 2019View details ↗
Phase 2RecruitingNCT01356290

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

👨‍⚕️ Andreas Peyrl, MD, Medical University of Vienna📍 22 sites📅 Started Apr 2014View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →